A generic version of semaglutide, more commonly known by the brand name Ozempic, is now available in Canada as patent protections expire. For The National, CBC’s Christine Birak breaks down the key details about the drug’s safety, production and cost.
Cheaper GLP-1s arrive in Canada: Are they safe?
- 2026-05-20, 6:06 PM
- cbc.ca
- 0
No comments